Internal Server Error

GlycoNex - About the company

GlycoNex is a public company based in Taipei (Taiwan), founded in 2001 by Tong-Hsuan Chang. It operates as a Developer of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies. The company has 436 active competitors, including 152 funded and 98 that have exited. Its top competitors include companies like BeiGene, Abcellera Biologics and Agios Pharmaceuticals.

Company Details

Developer of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies. The company’s technology platform enables glycosphingolipid antigen production and identification; monoclonal antibody production; cancer drug screening; stable cell line production for monoclonal antibody; and pharmacology/pharmacokinetics assessment.
Email ID
*****@glyconex.com.tw
Key Metrics
Founded Year
2001
Location
Taipei, Taiwan
Stage
Public
Ranked
Employee Count
28 as on Jul 31, 2026
Similar Companies
Exit Details
Public

GlycoNex's IPO details

GlycoNex got listed on Dec 18, 2012.
Click here to take a look at GlycoNex's IPO in detail
Sign up to download GlycoNex's company profile

GlycoNex's funding and investors

GlycoNex is a funded company.

GlycoNex's founders and board of directors

Founder? Claim Profile
The founders of GlycoNex is Tong-Hsuan Chang.
Here are the details of GlycoNex's key team members:

GlycoNex's employee count trend

GlycoNex has 28 employees as of Jul 26. Here is GlycoNex's employee count trend over the years:
Employee count trend for GlycoNex
lockUncover GlycoNex's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

GlycoNex's Competitors and alternates

Top competitors of GlycoNex include BeiGene, Abcellera Biologics and Agios Pharmaceuticals. Here is the list of Top 10 competitors of GlycoNex, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for BeiGene
BeiGene
2010, Cambridge (United States), Public
Developer of targeted and immune-oncology drugs against cancer
$172M
81/100
2nd
Logo for Abcellera Biologics
Abcellera Biologics
2012, Vancouver (Canada), Public
AI-enabled platform for antibodies discovery
$115M
71/100
3rd
Logo for Agios Pharmaceuticals
Agios Pharmaceuticals
2008, Cambridge (United States), Public
Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism
$120M
70/100
4th
Logo for TScan Therapeutics
TScan Therapeutics
1995, Boston (United States), Public
Developer of T cell therapies to harness the immune system against cancer
$180M
70/100
5th
Logo for BioNTech
BioNTech
2008, Mainz (Germany), Public
Developer of immunotherapeutics for the treatment of cancer and other diseases
$861M
69/100
6th
Logo for DBV Technologies
DBV Technologies
2002, Bagneux (France), Public
Developer of products for the treatment of various kinds of food allergies
$68.9M
68/100
7th
Developer of small molecule based therapeutics for cancer treatment
$55M
67/100
8th
Logo for Lyell Immunopharma
Lyell Immunopharma
2018, San Francisco (United States), Public
Developer of CAR- T therapy for cancer treatment
$493M
63/100
9th
Logo for ABL Bio
ABL Bio
2016, Seongnam-si (South Korea), Public
Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases
$65M
63/100
10th
Logo for Serum Institute of India
Serum Institute of India
1966, Pune (India), Funding Raised
Manufacturer of vaccines and immuno-biological drugs for infectious diseases
-
62/100
132nd
Logo for GlycoNex
GlycoNex
2001, Taipei (Taiwan), Public
Developer of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies
-
-
41/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on GlycoNex's competitors? Click here to see the top ones

GlycoNex's Investments and acquisitions

GlycoNex has made no investments or acquisitions yet.

Reports related to GlycoNex

Here is the latest report on GlycoNex's sector:

News related to GlycoNex

Media has covered GlycoNex for a total of 4 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about GlycoNex

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford